Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Virology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Transformation and Oncogenesis

Genome-Wide DNA Methylation as an Epigenetic Consequence of Epstein-Barr Virus Infection of Immortalized Keratinocytes

Christine E. Birdwell, Krista J. Queen, Phillip C. S. R. Kilgore, Phoebe Rollyson, Marjan Trutschl, Urska Cvek, Rona S. Scott
R. M. Longnecker, Editor
Christine E. Birdwell
bDepartment of Microbiology and Immunology, Louisiana State University Health Sciences Center—Shreveport, Shreveport, Louisiana, USA
cCenter for Molecular and Tumor Virology, Louisiana State University Health Sciences Center—Shreveport, Shreveport, Louisiana, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Krista J. Queen
bDepartment of Microbiology and Immunology, Louisiana State University Health Sciences Center—Shreveport, Shreveport, Louisiana, USA
cCenter for Molecular and Tumor Virology, Louisiana State University Health Sciences Center—Shreveport, Shreveport, Louisiana, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Phillip C. S. R. Kilgore
aDepartment of Computer Science, Louisiana State University—Shreveport, Shreveport, Louisiana, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Phoebe Rollyson
dDepartment of Biochemistry, Louisiana State University Health Sciences Center—Shreveport, Shreveport, Louisiana, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marjan Trutschl
aDepartment of Computer Science, Louisiana State University—Shreveport, Shreveport, Louisiana, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Urska Cvek
aDepartment of Computer Science, Louisiana State University—Shreveport, Shreveport, Louisiana, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rona S. Scott
bDepartment of Microbiology and Immunology, Louisiana State University Health Sciences Center—Shreveport, Shreveport, Louisiana, USA
cCenter for Molecular and Tumor Virology, Louisiana State University Health Sciences Center—Shreveport, Shreveport, Louisiana, USA
eFeist-Weiller Cancer Center, Louisiana State University Health Sciences Center—Shreveport, Shreveport, Louisiana, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. M. Longnecker
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JVI.00972-14
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Additional Files
  • FIG 1
    • Open in new tab
    • Download powerpoint
    FIG 1

    Transient infection of normal oral keratinocytes. (A) Schematic of transient infection of hTERT immortalized normal oral keratinocytes (NOK). A clonal NOK cell line was infected with a recombinant EBV (rEBV) carrying neomycin (neo) resistance and GFP cassettes in place of the BXLF1 gene. Neomycin selection pressure was applied to select and maintain EBV in the infected cell population. Removal of selection allowed loss of the viral episome (small black circles). Vector control indicates the clonal NOK cell line transfected with the PTRUF5 plasmid carrying the neomycin resistance and GFP cassettes. (B) In situ hybridization for EBV-encoded RNAs (EBERs) in uninfected, vector, EBV-positive and three EBV-negative transiently infected clones (EBV-cl1, EBV-cl3, and EBV-cl4). EBER positivity is indicated by dark nuclear staining in the EBV-positive cells. No EBER staining was detected in EBV-negative transiently infected clones. (C) DNA PCR spanning the viral genome in uninfected, vector, and EBV-positive (E+) clones and three EBV-negative transiently infected clones (EBV-cl 1, 3, and 4). The B cell line, Namalwa, with two integrated copies of EBV used as a limit of detection control at 100, 10, and 1 ng. (D) DNA PCR for the neomycin gene present in recombinant virus and vector plasmid. The EBV-positive cell line B958 was used as a positive control. Primers to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were used as a DNA loading control. (E) Southern blot for EBV genome using the EcoRI A fragment of the EBV genome as a probe in uninfected, vector, and EBV-positive clones and three transiently infected clones. U, uninfected; V, vector; E+, EBV-positive clone; 1, 3, and 4, transiently infected EBV-negative clones; W, water.

  • FIG 2
    • Open in new tab
    • Download powerpoint
    FIG 2

    Characterization of EBV-infected and transiently infected EBV-negative NOK. (A) Reverse transcriptase PCR for detection of latent and lytic viral transcripts in an uninfected clone (U), EBV-infected cell lines 1 and 2 (I1 and I2, respectively), and an EBV-positive clone from I1 (clone 4, cl4). B958 (+) was used as a positive control. W indicates water as the template control. (B) EBNA1 immunofluorescence analysis. Cells shown in the left panels were stained with the nuclear stain DAPI; EBNA1-positive cells are shown in red in the right panels. NOK E+ bulk, EBV-positive NOK cell line. (C) Southern blotting for detection of fused and linear EBV terminal repeats probed with the BamHI NJhet fragment. The asterisk denotes end fragments from linear EBV DNA. (D) Cell proliferation using an MTS [3,4-(5-dimethylthiazol-2-yl)-5-(3-carboxymethoxy phenyl)-2-(4-sulfophenyl)-2H-tetrazolium salt] assay was measured at 24-h intervals for 96 h. Shown are the average absorbance values and standard errors of the means from three independent biological experiments. (E) Transepithelial electrical resistance following calcium-induced differentiation. Data are the averages and standard errors of the means from three independent biological experiments. Lower TEER measurements for EBV-positive and EBV-negative transiently infected clones were statistically significant relative to uninfected and vector controls starting at days 4 to 9. (F) Involucrin (IVL) expression following methylcellulose treatment. Cells were either seeded as a monolayer (mono) or suspended in methylcellulose for 24 h (MC) to induce differentiation. qRT-PCR was used to quantify the amount of IVL transcripts relative to cyclophilin A (PPIA) transcripts. Data are the averages and standard errors of the means of two independent experiments. U, uninfected cells; V, vector control; EBV+, EBV-positive clone; EBV-cl 1, 3, and 4, three EBV-negative transiently infected clones.

  • FIG 3
    • Open in new tab
    • Download powerpoint
    FIG 3

    Methylome analysis of NOK by RRBS. (A) Distribution of mapped CpG residues in NOK. (B) Box-and-whisker plots comparing the distribution of methylated CpG residues between uninfected (U) cells, a vector control (V), an EBV-positive clone (EBV+), and three transiently infected EBV-negative clones (EBV-cl1, -cl3, and -cl4) at CpG islands, promoters, and within gene bodies. The yellow line across the bar represents the median level of methylation, the top whisker represents the maximum level of methylation, and the bottom whisker, which goes to 0, represents the minimum level of methylation.

  • FIG 4
    • Open in new tab
    • Download powerpoint
    FIG 4

    Distribution of differentially methylated CpG residues relative to the transcription start site (TSS). CpGs that either gained methylation (hypermethylated) or lost methylation (hypomethylated) in the EBV-positive and three EBV-negative transiently infected clones in relation to the uninfected and vector control were mapped relative to the TSS.

  • FIG 5
    • Open in new tab
    • Download powerpoint
    FIG 5

    CpG island hypermethylation as an epigenetic consequence of EBV infection of oral keratinocytes. (A) Number of hypermethylation events per locus. (B) Number of hypomethylation events per locus. Differentially methylated CpG residues that were located 500 bases from the previous CpG methylation event were counted. Blue bars indicate the number genes that acquired a certain number of methylation events, while red bars indicate CpG methylation at intergenic locations. (C to E) Methylation tracks at CpG islands in the NEDD4 binding protein 2-like 1 (N4BP2L1) gene, retinoic acid receptor responder 1 (RARRES1) gene, and protocadherin 19 (PCDH19) gene, respectively. Red bars represent unmethylated CpGs, and yellow bars represent methylated CpGs. Solid blue bars represent exons, and green bars represent CpG islands. Direction of transcription is indicated with blue or white arrows. Methylation tracks were visualized using the UCSC (University of California, Santa Cruz) Genome Browser. Samples shown are the uninfected parental control, vector control, an EBV-positive clone (EBV pos), and three EBV-negative transiently infected clones (EBV neg cl1, cl3, and cl4). hg19, human genome build 19.

  • FIG 6
    • Open in new tab
    • Download powerpoint
    FIG 6

    Methylation of the EBV genome in stably infected NOK. The outer circle displays the EBV genome position. The inner gray circle annotates select EBV genes, with purple bars showing rightward reading open reading frames and gold bars indicating the leftward reading open reading frames. Repetitive elements and origins of DNA replication are indicated as gray bars. The light gray circles map the positions of methylated (50 to 100% meCpG) and unmethylated (0 to 20% meCpG) CpG residues.

  • FIG 7
    • Open in new tab
    • Download powerpoint
    FIG 7

    Altered gene expression patterns as a consequence of EBV-induced epigenetic alterations. (A) Principle component analysis (PCA) of gene expression using a subset of 5,500 genes of uninfected (UN) cells, a vector control (vector), an EBV-positive clone (Pos), and three EBV-negative transiently infected clones (Neg cl1, -cl3, and -cl4). (B) Dendrogram based on PCA showing clustering of samples according to EBV exposure.

  • FIG 8
    • Open in new tab
    • Download powerpoint
    FIG 8

    Positional effect of DNA methylation on gene expression. (A) Differentially expressed genes were grouped according to whether the position of DNA methylation was near the TSS (<2,000 kb) or far from the TSS (>2,000 kb). (B) Distribution of methylation from the transcription start site (TSS) on differentially expressed genes (upregulated or downregulated) in an EBV-positive clone and the three EBV-negative transiently infected clones compared to uninfected cells and vector controls. Black horizontal bars indicated the mean distances of methylation from the TSS.

  • FIG 9
    • Open in new tab
    • Download powerpoint
    FIG 9

    Correlation of DNA methylation with repression of gene expression using the DNMT inhibitor, DAC. Bar graphs show the relative mRNA expression levels of MEIS homeobox protein 1 (MEIS1), cytoglobin (CYGB), HIV-1 Tat-interactive protein 2 (HTATIP2), protocadherin beta 6 (PCDHB6), PAS domain containing 1 (PASD1), and cyclophilin A (PPIA), respectively. NOK were treated with 1 μM DAC or an equal volume of DMSO as a vehicle control for 96 h. mRNA levels were determined by qRT-PCR and normalized to the level of hHPRT using the standard curve method. The relative RNA levels were determined by arbitrarily setting the uninfected (U), DMSO vehicle control to 1. Data are the averages and standard errors of the means from three independent biological treatments. In panels E and F, fold difference between the DAC-treated and DMSO vehicle control are shown. Right panels display the methylation tracks at regions where differential methylation was observed following EBV infection. These tracks were visualized using the UCSC (University of California, Santa Cruz) Genome Browser. Red bars represent unmethylated CpG residues; yellow bars represent methylated CpG residues.

Tables

  • Figures
  • Additional Files
  • TABLE 1

    Correlation of DNA methylation on differentially expressed genes in transiently infected clones compared to uninfected controls

    Gene group and symbolGene name or descriptionTotal no. of meCpGsaNo. of meCpGs (DMR)meCpG elementAvg TSS distance (bases)Fold change in expressionbP valueb
    Downregulated genes
        CYGBCytoglobin2424CGI385−1.90.027
        IGFBP7Insulin-like growth factor binding protein 777CGI278−1.90.001
        HTATIP2HIV-1 Tat-interactive protein 2, 30 kda55CGI433−5.50.001
        LINC00461Long intergenic non-protein coding RNA 461, microRNA 9-242CGI13,050−4.90.005
        SETD6SET domain containing 633Shore724−31.80.0001
        PASD1PAS domain containing 133None655−7.80.003
        PCDHB6Protocadherin beta 632Shore441−6.70.001
        HERC5Hect domain and RLD 533CGI354−2.00.042
        TSTD1Thiosulfate sulfurtransferase (rhodanese)-like domain containing 122CGI182−50.70.001
        ZC3HAV1LZinc finger CCCH-type, antiviral 1-like22CGI23−10.30.02
        TLR2Toll-like receptor 222CGI247−4.40.001
        NLGN1Neuroligin 122CGI713−3.20.022
        BEX2Brain expressed X-linked 222CGI123−3.30.001
        NPR2Natriuretic peptide receptor B/guanylate cyclase B (atrionatriuretic peptide receptor B)22CGI504−2.40.007
        RNLSRenalase, FAD-dependent amine oxidase22CGI280−2.10.003
        SESN3Sestrin 322CGI1,269−2.10.001
        B3GALNT1Beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)20CGI389−6.30.001
        PCDH10Protocadherin 1020CGI2,305−4.30.001
        SYKSpleen tyrosine kinase20None38,241−2.30.001
        FAM129BFamily with sequence similarity 129, member B20Shore61,403−1.90.006
        GPR158Signal transduction, G-protein-coupled receptor signaling pathway10CGI1,346−22.60.02
        BCAT1Branched chain amino acid transaminase 1, cytosolic10CGI824−5.40.001
        CCDC88CCoiled-coil domain containing 88C10CGI364−2.90.002
        NEFLNeurofilament, light polypeptide10CGI63−2.80.003
        HRASLSHRAS-like suppressor10CGI195−2.70.038
        DUOX1Dual oxidase 110CGI391−2.70.003
        CXCL1Chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)10Shore534−2.30.002
        THOC5THO complex 510Shore1,042−2.10.013
        MESTMesoderm-specific transcript homolog (mouse)10CGI5,220−2.00.033
        ERVMER34-1Endogenous retrovirus group MER34, member 110CGI408−1.90.009
        SLC12A8Solute carrier family 12 (potassium/chloride transporters), member 810Shore69,933−1.90.03
        ATP5J2-PTCD1ATP5J2-PTCD1 readthrough, pentatricopeptide repeat domain 110None8,656−1.90.004
        MMRN2Multimerin 210CGI14,572−1.80.011
    Upregulated genes
        FBXL16F-box and leucine-rich repeat protein 16207CGI9,2333.80.001
        FAM20CFamily with sequence similarity 20, member C135Shore90,1784.60.001
        COL5A1Collagen, type V, alpha 1123None83,2902.80.001
        ZIC2Zic family member 286CGI68210.70.013
        HS6ST2Heparan sulfate 6-O-sulfotransferase 287CGI3,9711.90.021
        TBX3T-box 375CGI9,7512.20.002
        EPHB2EPH receptor B273None92,7912.00.011
        AUTS2Autism susceptibility candidate73None1,148,9302.90.001
        SOBPSine oculis binding protein homolog (Drosophila)66CGI145,0776.70.009
        AGPAT31-Acylglycerol-3-phosphate O-acyltransferase 364None65,8172.60.005
        PLXND1plexin D155CGI7642.50.005
        APBA2Amyloid beta (A4) precursor protein-binding, family A, member 253CGI158,7882.40.019
        LEF1Lymphoid enhancer-binding factor 142CGI12,84467.60.001
        KCNH5Potassium voltage-gated channel, subfamily H (Eag-related), member 542CGI37,1861.90.001
        LINGO2Leucine-rich repeat and Ig domain containing 232None167,3761.950.033
        CYB561Cytochrome b-56130CGI1,9471.90.006
        WNT5AWingless-type MMTV integration site family, member 5A22CGI6,898460.001
        LINC00478Long intergenic non-protein coding RNA 47822None315,7301.80.03
        DOHHDeoxyhypusine hydroxylase/monooxygenase22None10,3091.810.011
        ADAMTS20ADAM metallopeptidase with thrombospondin type 1 motif, 2020CGI5094.00.001
        CXADRCoxsackie virus and adenovirus receptor10None25,2353.80.015
        SYTL4Synaptotagmin-like 410None7,8613.40.001
        HHIPHedgehog interacting protein10Shore9853.4
        RRAGDRas-related GTP binding D10CGI1913.00.047
        METTL20Methyltransferase-like 2010None1,4712.40.048
        LOC440173Uncharacterized LOC44017310CGI30,4542.30.006
        LOC283683/LOC646278Uncharacterized LOC283683, programmed cell death 6 interacting protein pseudogene10None52,5652.30.003
        IL21RInterleukin-21 receptor10None16,1582.10.038
        TRIML2Tripartite motif family-like 210CGI1,2801.90.04
        ABCA1ATP-binding cassette, subfamily A (ABC1), member 110None112,0911.90.003
        MYO5BMyosin VB10None255,6861.80.002
        CSMD1CUB and Sushi multiple domains 110None1,892,7861.80.041
    • ↵a meCpG, methylated CpG.

    • ↵b Change in expression relative to uninfected controls.

Additional Files

  • Figures
  • Tables
  • Supplemental material

    Files in this Data Supplement:

    • Supplemental file 1 -

      Fig. S1 (Top networks identified by Ingenuity Pathway Analysis described by transcriptional profiles from EBV-positive and EBV-negative transiently infected clones relative to those of uninfected controls.)

      PDF, 160K

    • Supplemental file 2 -

      Table S1 (Primers used in this study.)

      XLSX, 13K

    • Supplemental file 3 -

      Table S2 (Differential CpG methylation.)

      XLSX, 802K

    • Supplemental file 4 -

      Table S3 (EBV genome methylation.)

      XLSX, 215K

    • Supplemental file 5 -

      Table S4 (Top hypermethylated and hypomethylated genes.)

      XLSX, 10K

    • Supplemental file 6 -

      Table S5 (Differentially expressed genes.)

      XLSX, 39K

PreviousNext
Back to top
Download PDF
Citation Tools
Genome-Wide DNA Methylation as an Epigenetic Consequence of Epstein-Barr Virus Infection of Immortalized Keratinocytes
Christine E. Birdwell, Krista J. Queen, Phillip C. S. R. Kilgore, Phoebe Rollyson, Marjan Trutschl, Urska Cvek, Rona S. Scott
Journal of Virology Sep 2014, 88 (19) 11442-11458; DOI: 10.1128/JVI.00972-14

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Virology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Genome-Wide DNA Methylation as an Epigenetic Consequence of Epstein-Barr Virus Infection of Immortalized Keratinocytes
(Your Name) has forwarded a page to you from Journal of Virology
(Your Name) thought you would be interested in this article in Journal of Virology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Genome-Wide DNA Methylation as an Epigenetic Consequence of Epstein-Barr Virus Infection of Immortalized Keratinocytes
Christine E. Birdwell, Krista J. Queen, Phillip C. S. R. Kilgore, Phoebe Rollyson, Marjan Trutschl, Urska Cvek, Rona S. Scott
Journal of Virology Sep 2014, 88 (19) 11442-11458; DOI: 10.1128/JVI.00972-14
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About JVI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #Jvirology

@ASMicrobiology

       

 

JVI in collaboration with

American Society for Virology

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0022-538X; Online ISSN: 1098-5514